SANUWAVE Health Provides an Update on the DermaPACE

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SANUWAVE Health Provides an Update on the DermaPACE Clinical Trial

ALPHARETTA, Ga., May 6, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the independent Data Monitoring Committee (DMC) has performed an interim analysis on the efficacy and safety results in the Phase III supplemental clinical trial using the dermaPACE ® for treating diabetic foot ulcers.

The DMC performed an analysis of the primary efficacy endpoint of the rate of 100% complete wound closure at the 12-week endpoint for the dermaPACE treated patients as compared to the sham-control patients and the safety data. The DMC has completed its review and noted there were no safety issues. The DMC reported the Monitoring Success Criterion for the primary efficacy endpoint of 100% complete wound closure at 12 weeks has not been met and, assuming similar trends for any additional patents enrolled, will likely not be met at the next predefined analysis point of 170 patients. The Monitoring Success Criterion is a predictive probability of dermaPACE achieving statistical significance in the rate of 100% complete wound closure at 12 weeks as compared to the rate for sham-control.

As per its charter, the DMC's review was limited to only the 12-week endpoint data. The DMC has requested to the Company the ability to review complete closure rates at later points in the study, as patients were followed for up to 24 weeks and the DMC noted the Company had positive results at the 20-week endpoint in the first study of 206 patients completed in 2011.

SANUWAVE is actively working with the FDA regarding the data requests from the DMC. The interaction with the FDA will determine if the Company discontinues enrollment and moves to lock the database and unblind the data with the intention of filing a PMA with the FDA in late 2015, or continues the dermaPACE clinical study. The Company expects to have feedback from the FDA by the end of this quarter and will provide an update to shareholders at that time.

SANUWAVE retained Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) in January 2015 to lead the Company's interactions and correspondence with the FDA for the dermaPACE, which have already commenced. MCRA has successfully worked with the FDA on numerous PMAs for various musculoskeletal, restorative and general surgical devices since 2006.

Glenn Stiegman, MCRA's Vice President of Clinical and Regulatory Affairs, explained, "MCRA has been following the developments of the dermaPACE clinical trial process closely. We are pleased SANUWAVE has asked us to work with them to develop and execute an FDA strategy to assist in leading the dermaPACE to approvability."

Kevin A. Richardson II, Chairman of the board of directors of SANUWAVE, commented, "We chose MCRA for their extensive PMA experience with the FDA over the past decade. Their depth in regulatory and clinical science makes them an excellent partner for working hand-in-hand with our team and the FDA. We look forward to interactions with the FDA on enhancements to our rigorous study design. The dermaPACE, with its novel biologic regenerative effects, holds promise to heal diabetic foot ulcers and increase limb preservation, thus improving quality of life for these patients and their families and significantly easing the economic burden on an overwhelmed healthcare system that cares for these patients. We continue to work towards our ultimate goal of obtaining FDA approval for dermaPACE and commercializing the technology in the U.S. where millions of people suffer from costly and debilitating diabetic foot ulcers."

About M usculoskeletal Clinical Regulatory Advisers, LLC (MCRA) Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) is a leading adviser and clinical research organization for the medical device industry. MCRA's value to clients is the integration of five business value creators: regulatory, reimbursement, clinical research, healthcare compliance, and quality assurance. MCRA's integrated approach of these key value creating initiatives, as well as medical device specialization, provides unparalleled expertise for its clients. MCRA has offices in Washington, DC, Manchester, CT, and New York, NY, and serves more than 300 clients globally. For additional information, please visit:  www.mcra.com .

About SANUWAVE Health, Inc. SANUWAVE Health, Inc. ( www.sanuwave.com ) is a shock wave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. SANUWAVE's portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new vascularization and microcirculatory improvement, which helps restore the body's normal healing processes and regeneration. SANUWAVE applies its patented PACE technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Its lead product candidate for the global wound care market, dermaPACE ® , is CE Marked throughout Europe and has device license approval for the treatment of the skin and subcutaneous soft tissue in Canada, Australia and New Zealand. In the U.S., dermaPACE is currently under the FDA's Premarket Approval (PMA) review process for the treatment of diabetic foot ulcers. SANUWAVE researches, designs, manufactures, markets and services its products worldwide, and believes it has demonstrated that its technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) through its U.S. Class III PMA approved OssaTron ® device, as well as stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment through the utilization of its OssaTron, Evotron ® and orthoPACE ® devices in Europe, Asia and Asia/Pacific .  In addition, there are license/partnership opportunities for SANUWAVE's shock wave technology for non-medical uses, including energy, water, food and industrial markets.

Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company's product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company's ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.

For additional information about the Company, visit www.sanuwave.com .

DC Consulting, LLC 407-792-3333 SANUWAVE Health, Inc. Barry Jenkins Chief Financial Officer and COO 678-578-0103

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Blue Diamond's $1 Billion Brand Meets Farm Realities

Updated Category News Views 153

A Ten-Cent Signal Carries Real Weight A ten-cent edge over the industry benchmark may not excite the cocktail-party crowd, but almond growers notice every penny when fertilizer, power and pest control keep gnawing at the farm gate. Blue Diamond Growers says it delivered payments roughly 10 cents above the benchmark in its latest year, alongside net profit that came in...

Continue Reading
Rokt's 164% Growth Shows Checkout Ads Have Real Muscle

Updated Category News Views 193

Checkout screens have become valuable real estate, and Rokt is planting a flag right in the middle of them. The New York ecommerce technology company landed on Deloitte's 2026 Technology Fast 500 after posting 164% revenue growth from 2022 through 2025. That is a meaningful number, not decorative corporate confetti, especially in a digital-ad market where plenty of...

Continue Reading
TSA at 25: Security Mission Meets a Tough Travel Reality

Updated Category News Views 104

Twenty-five years after its birth from catastrophe, TSA is still carrying a job nobody should take lightly. The agency marked its anniversary on November 19, 2026, looking back to the September 11, 2001 attacks that led to federalized aviation screening and a permanent reshaping of how Americans move through airports. This is not the sort of milestone that deserves...

Continue Reading
Insta360 Tests Holiday Demand With $170 Gear Discounts

Updated Category News Views 143

A discount banner can reveal plenty about a hardware brand's priorities, and Insta360's latest Black Friday push is plainly built to put more of its ecosystem into customers' hands. The company is advertising savings of up to US$170 across cameras, gimbals, microphones, webcams, and accessories, with the promotion available for a limited time through its own store and...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 73

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
The Hanover Survey Puts Small-Business Trust on Trial

Updated Category News Views 297

A dark storefront can apparently erase goodwill faster than plenty of owners want to admit. The Hanover Insurance Group's 2026 Small Business Pulse Report found that 60% of surveyed consumers would temporarily buy from a competitor if their preferred small business shut unexpectedly. More than half would start looking elsewhere within a week. That is not a cute...

Continue Reading
PostalAnnex Adds Roseville Store as Owners Reach Three

Updated Category News Views 56

A third storefront from the same operators says more than a ribbon-cutting ever will. Aarondeep Hira and Manraj Sangha have opened a PostalAnnex in Roseville, California, their third Sacramento-area location after earlier operations in Sacramento and Antelope. For a franchise system, repeat ownership is the part worth noticing. It is not a guarantee of booming sales, and...

Continue Reading
Securitize Tests the IPO Clock With Anthropic Tokens

Updated Category News Views 55

Anthropic did not even get a full trading day to itself before the tokenization crowd arrived. Securitize says Anthropic stock became available through Securitize Stocks on Solana on the company’s first day as a public company, a loud little signal that the old IPO playbook is being prodded from the edges. For investors, this is not merely another crypto-flavored...

Continue Reading
Africa’s Digital Ownership Debate Gets More Serious

Updated Category News Views 58

Ownership was the uncomfortable word hanging over Cape Town on day two of Africa Tech Festival 2026, and frankly it should make investors sit up. Africa’s digital economy has no shortage of big promises, shiny AI demos or overseas executives talking about opportunity. The harder question is who funds the pipes, owns the data, makes the rules and actually keeps the...

Continue Reading
Africa’s Digital Leap Still Has a 64% Usage Problem

Updated Category News Views 5

A continent can be blanketed in signal and still feel digitally stranded. That is the stubborn fact sitting inside the GSMA Digital Africa Index 2026: mobile broadband reaches 92% of Africa’s population, while only 28% use mobile internet on their own devices. The 64% usage gap is not a rounding error or a tidy policy footnote. It is the whole unfinished job. From an...

Continue Reading

Top 5 Most Recently Viewed Articles

Pacific Valley Bancorp Delivers Financial Performance Insights

Updated Category News Views 246

Financial Overview of Pacific Valley Bancorp Pacific Valley Bancorp, a holding company for Pacific Valley Bank, has shared its third-quarter financial results, indicating noteworthy trends and developments in its financial landscape. The bank reported a net income of $950 thousand for the quarter, reflecting a 16.5% decrease from the previous year's performance largely...

Continue Reading
KULR Enhances AI Data Center Energy Solutions with OCP Membership

Updated Category News Views 176

KULR Technology Group Joins Open Compute Project as Platinum Member KULR Technology Group, Inc. (NYSE American: KULR) is making significant strides in the energy storage landscape by joining the Open Compute Project (OCP) as a Platinum Member. This partnership comes at a time when the demand for innovative energy solutions in AI data centers is surging. KULR, known for...

Continue Reading
Investors of XPLR Infrastructure, LP Could Join Class Action

Updated Category News Views 90

Investors Encouraged to Join Class Action Against XPLR Infrastructure Levi & Korsinsky, LLP is reaching out to investors of XPLR Infrastructure, LP, formerly known as Nextera Energy Partners, LP, to inform them about a class action securities lawsuit. The company, identified by the ticker symbol XIFR, is currently facing allegations of securities fraud that potentially...

Continue Reading
Understanding Teck Resources' Recent Options Movements

Updated Category News Views 151

Investors Keeping a Close Eye on Teck Resources Recently, it has been observed that financial investors have adopted a bullish outlook regarding Teck Resources (TECK). This perspective is important for both seasoned and retail traders in the market. The activity on Teck’s options historically gives valuable insights, particularly in dynamic trading environments....

Continue Reading
Understanding the Class Action Lawsuit Against Lineage, Inc.

Updated Category News Views 201

Overview of Class Action Lawsuit Lineage, Inc. (NASDAQ: LINE) is currently facing a class action lawsuit that has garnered significant attention from shareholders and the legal community alike. This lawsuit represents individuals who purchased shares of Lineage's common stock during a specific class period linked to the company's registration statement from its initial...

Continue Reading